TrialSteroids2018

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.

Eric P Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.